Literature DB >> 14504285

GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptor.

Caroline Diveu1, Eric Lelièvre, David Perret, Anne-Hélène Lagrue Lak-Hal, Josy Froger, Catherine Guillet, Sylvie Chevalier, François Rousseau, Amy Wesa, Laurence Preisser, Marie Chabbert, Jean-François Gauchat, Anne Galy, Hugues Gascan, Alain Morel.   

Abstract

We describe a novel cytokine receptor named GP130 Like receptor, or GPL, that displays similarities with the interleukin-6 and interleukin-12 family of signaling receptors. Four different isoforms diverging in their carboxyl terminus were isolated, corresponding to proteins encompassing 560, 610, 626, and 745 amino acids. Sequences included a signal peptide of 32 amino acids, followed by a cytokine binding domain containing four conserved cysteines, a WSDWS motif, and a region consisting of three fibronectin type III domain repeats. No immunoglobulin-like module was identified in the GPL sequences. The intracellular part of longer isoforms contained a proline-rich region defining a box1 motif for interaction with the Janus kinases. The Gpl gene is organized in 15 exons and is located on 5q11.2 in tandem with the gp130 gene. Both genes were only separated by 24 kilobases, with opposite transcriptional orientations. The GPL receptor displayed a 28% identity with gp130. Specific GPL transcripts were observed in tissues involved in reproduction. Transcripts were also found in blood cells and in bone marrow, revealing expression of GPL in all of the myelomonocytic lineage, from hematopoietic stem cells to activated dendritic cells. In monocytes and dendritic cells, expression of GPL was strongly up-regulated by interferon-gamma, indicating a possible involvement of GPL in Th1-type immune responses. The molecular basis of cell signaling mediated by GPL was studied using chimeric receptors where external portions of alpha or beta interleukin-5 receptor subunits were fused to the internal portion of GPL or of related receptors. Results indicated that association of GPL to the intracellular portions of gp130, or LIF receptor, allowed the signaling cascade.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504285     DOI: 10.1074/jbc.M307286200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Definition and characterization of an inhibitor for interleukin-31.

Authors:  Emilie Venereau; Caroline Diveu; Linda Grimaud; Elisa Ravon; Josy Froger; Laurence Preisser; Yannic Danger; Mike Maillasson; Laure Garrigue-Antar; Yannick Jacques; Sylvie Chevalier; Hugues Gascan
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

2.  Regulation of myeloid progenitor cell proliferation/survival by IL-31 receptor and IL-31.

Authors:  Hal E Broxmeyer; Ji Li; Giao Hangoc; Scott Cooper; Wen Tao; Charlie Mantel; Barbara Graham-Evans; Nico Ghilardi; Frederic J de Sauvage
Journal:  Exp Hematol       Date:  2007-04       Impact factor: 3.084

3.  Feline Interleukin-31 Shares Overlapping Epitopes with the Oncostatin M Receptor and IL-31RA.

Authors:  Angelica V Medina-Cucurella; Gary F Bammert; William Dunkle; Christopher Javens; Yaqi Zhu; Veronica T Mutchler; Janet T Teel; Caitlin A Stein; Steve A Dunham; Timothy A Whitehead
Journal:  Biochemistry       Date:  2020-06-04       Impact factor: 3.162

Review 4.  IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Micah Belzberg; Madan M Kwatra; Shawn G Kwatra
Journal:  Drugs       Date:  2021-04-21       Impact factor: 9.546

5.  Association between Interleukin 31 Receptor A Gene Polymorphism and Schizophrenia in Korean Population.

Authors:  Ju Yeon Ban; Su Kang Kim; Hak-Jae Kim; Joo-Ho Chung; Tae Kim; Jin Kyung Park; Hyun-Kyung Park; Jong Woo Kim
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

6.  A short receptor downregulates JAK/STAT signalling to control the Drosophila cellular immune response.

Authors:  Rami Makki; Marie Meister; Delphine Pennetier; Jean-Michel Ubeda; Anne Braun; Virginie Daburon; Joanna Krzemień; Henri-Marc Bourbon; Rui Zhou; Alain Vincent; Michèle Crozatier
Journal:  PLoS Biol       Date:  2010-08-03       Impact factor: 8.029

7.  Molecular dissection of human interleukin-31-mediated signal transduction through site-directed mutagenesis.

Authors:  Sabine Le Saux; François Rousseau; Fabien Barbier; Elisa Ravon; Linda Grimaud; Yannic Danger; Josy Froger; Sylvie Chevalier; Hugues Gascan
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

Review 8.  Structures and biological functions of IL-31 and IL-31 receptors.

Authors:  Qing Zhang; Prabhakar Putheti; Qiang Zhou; Quansheng Liu; Wenda Gao
Journal:  Cytokine Growth Factor Rev       Date:  2008-10-15       Impact factor: 7.638

9.  The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.

Authors:  E Ferretti; C Tripodo; G Pagnan; C Guarnotta; D Marimpietri; M V Corrias; D Ribatti; S Zupo; G Fraternali-Orcioni; J L Ravetti; V Pistoia; A Corcione
Journal:  Leukemia       Date:  2014-10-06       Impact factor: 11.528

10.  The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus.

Authors:  Hua-Tuo Huang; Jian-Ming Chen; Jing Guo; Yan Lan; Ye-Sheng Wei
Journal:  Rheumatol Int       Date:  2016-01-14       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.